Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Prognostic Value of Translocation 11;14 in...
Conference

Prognostic Value of Translocation 11;14 in Patients with Relapsed/Refractory Myeloma Receiving Anti-CD38 Therapy

Authors

Mohyuddin GR; Chakraborty R; Calip G; Ascha MS; Wang X; Rubinstein S; Tuchman SA; Costa LJ; Haaland B; Giri S

Volume

140

Pagination

pp. 5223-5224

Publisher

American Society of Hematology

Publication Date

November 15, 2022

DOI

10.1182/blood-2022-165541

Conference proceedings

Blood

Issue

Supplement 1

ISSN

0006-4971